Page last updated: 2024-08-24

valsartan and Viral Diseases

valsartan has been researched along with Viral Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Javor, S; Salsano, A	1
Balmforth, C; Jhund, PS; Lefkowitz, M; McMurray, JJV; Packer, M; Rizkala, AR; Rouleau, JL; Shen, L; Shi, V; Simpson, J; Solomon, SD; Swedberg, K; Zile, MR	1
Tullus, K	1

Trials

1 trial(s) available for valsartan and Viral Diseases

Article	Year
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC. Heart failure, 2019, Volume: 7, Issue:6 Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiomyopathy, Alcoholic; Cardiomyopathy, Dilated; Cardiotoxicity; Cardiovascular Diseases; Cause of Death; Dangerous Behavior; Diabetic Cardiomyopathies; Drug Combinations; Enalapril; Female; Heart Failure; Heart Valve Diseases; Hospitalization; Humans; Hypertension; Infections; Male; Middle Aged; Mortality; Myocardial Ischemia; Peripartum Period; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Virus Diseases	2019

Article

Year

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

JACC. Heart failure, 2019, Volume: 7, Issue:6

Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiomyopathy, Alcoholic; Cardiomyopathy, Dilated; Cardiotoxicity; Cardiovascular Diseases; Cause of Death; Dangerous Behavior; Diabetic Cardiomyopathies; Drug Combinations; Enalapril; Female; Heart Failure; Heart Valve Diseases; Hospitalization; Humans; Hypertension; Infections; Male; Middle Aged; Mortality; Myocardial Ischemia; Peripartum Period; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Virus Diseases

2019

Other Studies

2 other study(ies) available for valsartan and Viral Diseases

Article	Year
Why not consider an endothelin receptor antagonist against SARS-CoV-2? Medical hypotheses, 2020, Volume: 141 Topics: Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Bosentan; Cells, Cultured; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Humans; Models, Biological; Pandemics; Pneumonia, Viral; Receptor, Endothelin A; RNA, Viral; SARS-CoV-2; Valsartan; Virus Diseases	2020
Safety concerns of angiotensin II receptor blockers in preschool children. Archives of disease in childhood, 2011, Volume: 96, Issue:9 Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Child, Preschool; Clinical Trials as Topic; Female; Gastroenteritis; Humans; Infant; Male; Nephrotic Syndrome; Tetrazoles; Valine; Valsartan; Virus Diseases	2011

Article

Year

Why not consider an endothelin receptor antagonist against SARS-CoV-2?

Medical hypotheses, 2020, Volume: 141

Topics: Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Bosentan; Cells, Cultured; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Humans; Models, Biological; Pandemics; Pneumonia, Viral; Receptor, Endothelin A; RNA, Viral; SARS-CoV-2; Valsartan; Virus Diseases

2020

Safety concerns of angiotensin II receptor blockers in preschool children.

Archives of disease in childhood, 2011, Volume: 96, Issue:9

Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Child, Preschool; Clinical Trials as Topic; Female; Gastroenteritis; Humans; Infant; Male; Nephrotic Syndrome; Tetrazoles; Valine; Valsartan; Virus Diseases

2011